Montelukast sodium and Apraxia - a phase IV clinical study of FDA data

Summary:

Apraxia is reported only by a few people who take Montelukast Sodium.

The phase IV clinical study analyzes which people take Montelukast sodium and have Apraxia. It is created by eHealthMe based on reports of 17,423 people who have side effects while taking Montelukast sodium from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Oct, 01, 2022

17,423 people reported to have side effects when taking Montelukast sodium.
Among them, 3 people (0.02%) have Apraxia.


What is Montelukast sodium?

Montelukast sodium has active ingredients of montelukast sodium. It is often used in asthma. eHealthMe is studying from 18,487 Montelukast sodium users for its effectiveness, alternative drugs and more.

What is Apraxia?

Apraxia (disorder that affects a person's ability to organize the movements of the muscles used in speech) is found to be associated with 1,010 drugs and 837 conditions by eHealthMe.

Number of Montelukast sodium and Apraxia reports submitted per year:

Could Montelukast sodium cause Apraxia?

Time on Montelukast sodium when people have Apraxia *:

  • < 1 month: 0.0 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 100 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Apraxia when taking Montelukast sodium *:

  • female: 0.0 %
  • male: 100 %

Age of people who have Apraxia when taking Montelukast sodium *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 100 %

Common drugs people take besides Montelukast sodium *:

  1. Dymista: 3 people, 100.00%

Common side effects people have besides Apraxia *:

  1. Weakness: 3 people, 100.00%
  2. Hypoaesthesia (reduced sense of touch or sensation): 3 people, 100.00%
  3. Amaurosis Fugax (painless transient monocular visual loss): 3 people, 100.00%

Common conditions people have *:

  1. Rhinitis (a medical term for irritation and inflammation of the mucous membrane inside the nose): 3 people, 100.00%
  2. Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 1 person, 33.33%

* Approximation only. Some reports may have incomplete information.

Do you take Montelukast sodium and have Apraxia?

Check whether Apraxia is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related publications that referenced our studies

Related studies

How severe was Apraxia and when was it recovered:

Expand to all the drugs that have ingredients of montelukast sodium:

Alternative drugs to, pros and cons of Montelukast sodium:

Common Montelukast sodium side effects:

Browse all side effects of Montelukast sodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Apraxia treatments and more:

COVID vaccines that are related to Apraxia:

All the drugs that are associated with Apraxia:

Common conditions associated with Apraxia:

All the conditions that are associated with Apraxia:

How the study uses the data?

The study uses data from the FDA. It is based on montelukast sodium (the active ingredients of Montelukast sodium) and Montelukast sodium (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: